Use of oral diazoxide for the treatment of disorders in...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/54 (2006.01)

Patent

CA 2161332

A method is disclosed for normalizing blood glucose and insulin levels as measured by an oral glucose tolerance test in an individual exhibiting normal fasting blood glucose and insulin levels and exhibiting in an oral glucose tolerance test elevated glucose levels and at least one insulin level abnormality selected from the group consisting of a delayed insulin peak. an exaggerated insulin peak and a secondary elevated insulin peak. The method comprising administering diazoxide to the individual before ingestion of a food source in an amount effective to normalize the blood glucose and insulin levels. Diazoxide is administered in an amount from about 0.4 to about 0.8 mg/kg body weight before each meal.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of oral diazoxide for the treatment of disorders in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of oral diazoxide for the treatment of disorders in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of oral diazoxide for the treatment of disorders in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1992363

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.